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Anti-Apoptotic Effects 
of Caspase Inhibitors on 
Rat Intervertebral Disc Cells
BY JONG-BEOM PARK, MD, PHD, IN-CHUL PARK, PHD, SUNG-JIN PARK, MD, HYEON-OK JIN, BS, 
JIN-KYUNG LEE, MD, PHD, AND K. DANIEL RIEW, MD
Investigation performed at The Catholic University of Korea School of Medicine, Seoul, Republic of Korea
Background: Apoptosis is thought to be a critical component of disc degeneration. Two main pathways of Fas-mediated
apoptosis have been identified: Type I, which is the death-inducing signaling complex pathway, and Type II, which is the
mitochondrial pathway. The apoptotic pathway for anulus fibrosus cells, which is phenotypically different from that of nu-
cleus pulposus cells, has not been elucidated to our knowledge. The ultimate initiators or executioners of apoptosis are
caspases. There are also inhibitors of caspases, which have the potential of being used as anti-apoptotic therapeutic
agents. We therefore undertook this study to determine (1) the apoptotic pathway of anulus fibrosus cells and (2) the
anti-apoptotic potential of caspase inhibitors.
Methods: Rat anulus fibrosus cells were isolated, cultured, and placed in either 0% (apoptosis-promoting condition)
or 10% (normal control) fetal bovine serum. We identified and quantified the presence of apoptotic cell death,
caspase activities, and loss of mitochondrial membrane potential. In addition, we examined the cells for the expres-
sion of Fas, procaspases, and cytochrome-c. Finally, we analyzed the degree of anti-apoptotic effects of caspase in-
hibitors on the cells in 1% fetal bovine serum.
Results: The percentage of apoptosis and Fas expression in the cells incubated in 0% fetal bovine serum were in-
creased compared with those in the cells incubated in 10% fetal bovine serum (both p < 0.001). Caspase-8, 9, and 3
activities were increased and expression of procaspases was decreased in the 0% fetal bovine serum compared with
those in the 10% fetal bovine serum (all p < 0.001). In contrast, the loss of mitochondrial membrane potential and
cytochrome-c release into the cytosol were unchanged in the 0% fetal bovine serum. Pancaspase and caspase-8 in-
hibitors reduced apoptotic cell death (p < 0.001 and p < 0.05, respectively), but caspase-9 inhibitor did not reduce
apoptotic cell death.
Conclusions: Our results suggest that, unlike nucleus pulposus cells, anulus fibrosus cells are Fas Type-I cells,
which undergo apoptosis through the death-inducing signaling complex. We also found that apoptosis of interverte-
bral disc cells can be attenuated by caspase inhibitors.
Clinical Relevance: Caspase inhibitors may play a therapeutic role in slowing disc degeneration that is due to inap-
propriate or excessive apoptosis of intervertebral disc cells.
poptosis, or programmed cell death, is mediated by the
activation of caspases (cysteine-containing aspartate-
specific proteases, a group of proteolytic enzymes) and
is thought to be a critical component of acute and chronic dis-
eases such as myocardial infarction, stroke, neurodegenerative
diseases, and disc degeneration1-3. There are several caspases,
and they act as either initiators (caspase-2, 8, and 9) or execu-
tioners (caspase-3, 6, and 7) of apoptosis4,5. The initiator caspases
make it possible for the executioner caspases to catalyze a series
of proteolytic events, resulting in the characteristic biochemical
and morphological changes associated with apoptosis. There
are also inhibitors of caspases, which have the potential to be
used as anti-apoptotic agents6,7. The potential therapeutic use of
caspase inhibitors has been explored in animal models for such
conditions as cerebral and cardiac ischemia and sepsis8-13. To our
knowledge, however, therapeutic caspase inhibition to prevent
or attenuate apoptosis in intervertebral disc cells has not been
previously investigated.
The Fas receptor is a member of the tumor-necrosis fac-
tor (TNF) receptor superfamily and is expressed at the plasma
membrane in a wide range of tissues, including intervertebral
discs5,14-17. Ligation of the Fas ligand or a cross-linking anti-
body to the Fas receptor induces apoptosis in susceptible cells,
resulting in the recruitment and autocleavage of the initiator
A
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caspase, procaspase-8, at the plasma membrane.
Two major pathways of Fas-mediated apoptosis have
been identified (Fig. 1)5,14,17: the Type-I (death-inducing signal-
ing complex) pathway and the Type-II (mitochondrial) path-
way. In Type-I cells, activation of the Fas death receptor on the
cell membrane results in the formation of the death-inducing
signaling complex, made up of intracellular proteins and
caspase-8. This complex activates large quantities of caspase-8,
which activates caspase-3 and caspase-7 (executioner caspases).
The executioner caspases then destroy the cell’s cytoskeletal and
reparative proteins. The initiation of cell death occurs at the
cell-membrane level rather than at the mitochondria.
In Type-II (mitochondrial) cells, death is initiated at the
mitochondria. Unlike in Type-I cells, the quantity of caspase-8
is insufficient to directly activate the executioner caspase-3.
Instead, it activates Bid (BH3 interacting domain death ago-
nist), which interferes with mitochondrial function by inhibit-
ing Bcl-2, an apoptosis-inhibiting protein on the outer wall of
mitochondria. Blocking Bcl-2 increases the permeability of
the mitochondrial membrane, allowing intramitochondrial
proteins to escape into the cytosol. One of these proteins is
cytochrome-c, which is essential to mitochondrial survival.
The extruded cytochrome-c activates caspase-9, which in turn
activates caspase-3, the executioner, resulting in cell apoptosis.
Our recent investigations suggested that human lumbar
nucleus pulposus cells undergo Fas Type-II (mitochondrial
pathway) apoptotic cell death18. However, the apoptotic path-
way for anulus fibrosus cells, which is phenotypically different
from that of nucleus pulposus cells, has not been clearly deter-
mined. Defining the specific pathway for a cell type is the nec-
essary first step to finding a selective therapeutic intervention
to modulate apoptosis. We therefore undertook this study to
determine the apoptotic pathway of anulus fibrosus cells and
the anti-apoptotic potential of caspase inhibitors.
Materials and Methods
Cell Culture and Reagents
ll lumbar intervertebral discs were harvested from three
male Sprague-Dawley rats (four months of age) immedi-
ately after they were killed. We carefully dissected the discs un-
der the microscope to obtain only outer anulus fibrosus tissue,
and we cultured the tissue in Dulbecco modified Eagle medium
supplemented with 10% fetal bovine serum, 100 U/mL of peni-
cillin, and 100 μg/mL of streptomycin under 5% CO2 in a hu-
midified incubator at 37°C for twelve hours. To isolate the cells,
outer anulus fibrosus tissues in Dulbecco modified Eagle me-
dium were digested with 0.2% pronase (Sigma Chemical, St.
Louis, Missouri) for four hours. After enzymatic digestion, the
suspension was filtered through a 70-μm mesh (Falcon, Frank-
lin Lakes, New Jersey). The filtered cells were then washed with
A
Fig. 1
Fas-mediated apoptotic signaling pathways. In Type-I cells, Fas triggering leads to strong caspase-8 activation 
at the death-inducing signaling complex (DISC), which bypasses mitochondria, leading directly to the activation 
of executioner caspases such as caspase-3 and subsequently to apoptosis. In Type-II cells, only a little DISC 
is formed, leading to the cleavage of Bid, a proapoptotic member of the Bcl-2 family. The cleaved Bid induces 
the release of cytochrome-c from mitochondria, which then activates caspase-9. Caspase-9 then activates 
caspase-3. The activated caspase-3 in both Type-I and Type-II cells then cleaves various cellular substrates to 
cause apoptosis.
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Dulbecco modified Eagle medium and used as the primary cul-
ture. After three passages, the cells were trypsinized and were
subcultured into six-well plates at 3 × 105 cells per well.
Z-IETD-FMK (caspase-8 inhibitor), Z-LEHD-FMK
(caspase-9 inhibitor), Z-VAD-FMK (pancaspase inhibitor), and
Boc-D-FMK (pancaspase inhibitor) were purchased from Cal-
biochem (San Diego, California) and staurosporine was pur-
chased from Sigma-Aldrich (St. Louis, Missouri). Antibodies
against Fas; procaspase-3, 8, and 9; and β-actin were purchased
from Santa Cruz Biotechnology (Santa Cruz, California) , and
antibody against cytochrome-c was obtained from BD Bio-
sciences Pharmingen (San Diego, California).
Evaluation of Apoptosis
Apoptosis was determined by staining cells with both annexin
V-FITC (PharMingen, San Diego, California) and propidium
iodide (PharMingen), according to the manufacturer’s instruc-
tions. Annexin V-FITC is used to quantitatively determine the
percentage of cells undergoing apoptosis. It relies on the prop-
erty of cells to lose membrane asymmetry in the early phase of
apoptosis. In apoptotic cells, the membrane phospholipid phos-
phatidylserine is translocated from the inner leaflet of the
plasma membrane to the outer leaflet, thereby exposing phos-
phatidylserine to the external environment. Annexin V is a
Ca2+-dependent phospholipids-binding protein that has a high
affinity for phosphatidylserine and is useful for identifying apop-
Fig. 2-A
Figs. 2-A and 2-B Evaluation of apoptosis. Rat anulus fibrosus cells were treated with 10% or 0% 
fetal bovine serum for forty-eight hours. Cells treated with 0.5 μM staurosporine (STS) for twenty-
four hours were used as a positive control for apoptosis. Fig. 2-A Cell death was assayed with 
flow cytometry after double staining with annexin V-FITC and propidium iodide.
Fig. 2-B
The percentages of apoptotic cell death, expressed as the mean and 
standard deviation of three independent experiments. ***p < 0.001.
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totic cells with exposed phosphatidylserine. It is typically conju-
gated to a fluorochrome, such as fluorescein isothiocyanate
(FITC), for easy identification of apoptotic cells by flow cyto-
metry. Propidium iodide is a standard flow cytometric viabil-
ity probe and is used to distinguish viable from nonviable
cells. Viable cells with an intact membrane exclude propidium
iodide, whereas the membranes of dead and damaged cells are
permeable to propidium iodide. Cells that stain positive for an-
nexin V-FITC and negative for propidium iodide are undergoing
apoptosis. Cells that stain positive for both annexin V-FITC
and propidium iodide are undergoing necrosis19,20. To quantitate
apoptosis, cells were washed with cold phosphate-buffered saline
solution and then suspended in binding buffer (10 mM HEPES/
NaOH [pH 7.4], 140 mM NaCl, and 2.5 mM CaCl2). The cells
were stained with 5 μL of annexin V-FITC and 10 μL of pro-
pidium iodide and then analyzed with FACScan flow cytometry
(Becton Dickinson, San Jose, California) at twenty-four and
forty-eight hours. The cells treated with 0.5 μM staurosporine
(Calbiochem) for twenty-four hours were used as positive con-
trols for apoptosis. Staurosporine is a broad-spectrum protein
kinase inhibitor that induces apoptosis by markedly increasing
cytochrome-c in the cytosol of a variety of cell types21,22.
Measurement of Caspase Activations
Enzymatic activity of caspase-3, 8, and 9 was determined by the
CaspaTag Caspase-3/7, 8, and 9 In Situ Assay Kit (Chemicon,
Temecula, California) according to the manufacturer’s in-
structions. Briefly, this kit uses a carboxyfluorescein-labeled
fluoromethyl ketone peptide inhibitor of caspase-3/7 (FAM-
DEVD-FMK), caspase-8 (FAM-LETD-FMK), and caspase-
9 (FAM-LEHD-FMK), which produces a green fluorescence.
These reagents enter each cell and covalently bind to a reactive
cysteine residue on the large submit of the active caspase
heterodimer, thereby inhibiting further enzymatic activity. Cells
that contain the bound labeled reagent were analyzed with
FACScan flow cytometry at twenty-four and forty-eight hours.
Assay of Mitochondrial Membrane Potential
Mitochondrial membrane potential was measured with a volt-
age-sensitive lipophilic cationic fluorescent probe, 5,5′,6,6′-
tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbo cyanine io-
dide (JC-1). Briefly, cells (1 × 105) were washed with cold
phosphate-buffered saline solution and JC-1 (5 μg/mL) and
were then added to the incubation buffer. The cells were then
incubated in 10% or 0% fetal bovine serum for fifteen min-
utes, washed with incubation buffer, and analyzed with FACS-
can flow cytometry at forty-eight hours. Cells treated with 0.5
μM staurosporine for twenty-four hours were used as a posi-
tive control for apoptosis.
Subcellular Fractionation
To analyze the distribution of cytochrome-c, the cells were
fractionated into cytosolic and membrane-bound organellar
fractions with extraction buffer containing 220 mM mannitol,
70 mM sucrose, 50 mM PIPES-KOH (pH 7.4), 50 mM KCl, 5
mM EGTA, 2 mM MgCl2, 1 mM EDTA, 1 mM DTT (dithio-
threitol), and protease inhibitor cocktail (Roche, Mannheim,
Germany). After thirty minutes of incubation on ice, the cells
were homogenized with use of a glass Dounce homogenizer.
The cell homogenates were centrifuged at 12,000 g for thirty
minutes, and the resulting supernatant was taken as the cyto-
solic fraction.
Western Blot Analysis
Expressions of Fas; procaspase-3, 8, and 9; and cytochrome-c
were determined by Western blot analysis according to the
manufacturer’s instructions. β-actin was used as an internal
control for protein-loading. Briefly, the cells were washed with
ice-cold phosphate-buffered saline solution and lysed in RIPA
(radioimmunoprecipitation assay) buffer. The cell lysates were
centrifuged at 12,000 g for fifteen minutes, and protein concen-
Fig. 4-A
Fig. 3
Western blot analysis showing expression of Fas in cells treated with 
0% fetal bovine serum for forty-eight hours but not in cells treated with 
10% fetal bovine serum for forty-eight hours.
Figs. 4-A, 4-B, and 4-C Assay of caspase activations. Fig. 4-A Western 
blot analysis showing clearly decreased expression of procaspase-8, 9, 
and 3 in the cells treated with 0% fetal bovine serum for forty-eight hours.
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trations were measured with the Bradford method23. Samples
(20 to 40 μg of protein) were electrophoresed on 10% to 15%
SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis) and transferred to a nitrocellulose membrane. The
membranes were incubated with primary antibodies, followed
by second antibodies of HRP (horseradish peroxidase)-linked
IgG (immunoglobulin G), and immunoreactive bands were vi-
sualized with the Amersham ECL detection system (Amersham,
Piscataway, New Jersey).
Assay of Anti-Apoptotic Effects of Caspase Inhibitors
Anulus fibrosus cells were incubated with 1% fetal bovine
serum, which is necessary for basal cell maintenance, with
and without Z-IETD-FMK (caspase-8 inhibitor, 100 μM), Z-
LEHD-FMK (caspase-9 inhibitor, 100 μM), Z-VAD-FMK
(pancaspase inhibitor, 100 μM), and Boc-D-FMK (pancaspase
inhibitor, 100 μM) for forty-eight hours. This concentration
of caspase inhibitors has been shown to inhibit caspase-3, 8,
and 9, respectively. Apoptotic cell death was determined by
double staining with 5 μL of annexin V-FITC and 10 μL of
propidium iodide followed by analysis with FACScan flow cy-
tometry at forty-eight hours.
Statistical Analysis
All experiments were independently conducted three times, and
the results were expressed as the mean and standard deviation
of the values derived with the three tests. Statistical analysis was
done with the paired-samples and independent-samples t test.
P < 0.05 was considered to be the level of significance.
Results
Apoptosis of Rat Anulus Fibrosus Cells 
Through Fas Upregulation
e first tested the effect of serum deprivation on the apop-
tosis of rat anulus fibrosus cells. Figures 2-A and 2-B
show that rat anulus fibrosus cells treated for twenty-four hours
and forty-eight hours solely with 0% fetal bovine serum dis-
played apoptotic cell death, as determined by double staining
with annexin V-FITC and propidium iodide. The mean per-
centage of apoptotic cell death in 0% fetal bovine serum was
significantly increased compared with that in 10% fetal bovine
serum at twenty-four hours (44% compared with 5%, p <
0.001) and forty-eight hours (56% compared with 6%, p <
0.001). The upregulation of Fas expression was identified in 0%
fetal bovine serum but not in 10% fetal bovine serum on West-
W
Fig. 4-B
Caspase activations were analyzed by flow cytometry with use of a caspase-3/7, 8, and 9 In Situ 
Assay Kit. 
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ern blot analysis (Fig. 3). These results strongly suggest that up-
regulation of Fas expression is responsible for apoptosis of rat
anulus fibrosus cells induced by serum deprivation.
Fas-Mediated Apoptosis of Rat Anulus 
Fibrosus Cells Requires Activation of Caspases
To characterize the Fas-mediated apoptotic pathway triggered by
serum deprivation in rat anulus fibrosus cells, we measured dif-
ferent apoptotic induction markers downstream to Fas, such as
caspase-8, 9, and 3 activations. Anulus fibrosus cells treated with
0% fetal bovine serum for forty-eight hours showed clearly
decreased expression of procaspase-8, 9, and 3 on Western blot
analysis (Fig. 4-A), suggesting that procaspases were converted to
active caspases. This was associated with significant increases in
the activities of the activations of caspase-8, 9, and 3 of 4.3 times
(p < 0.001), 2.5 times (p < 0.001), and 2.8 times (p < 0.001), re-
spectively (Figs. 4-B and 4-C). In anulus fibrosus cells treated
with 0% fetal bovine serum for twenty-four hours, caspase-8 ac-
tivity was increased earlier than was caspase-9 activity.
Fas-Mediated Apoptosis of Rat Anulus Fibrosus Cells 
Is Not Associated with a Mitochondrial Pathway
No substantial change in the mitochondrial membrane poten-
tial was found in anulus fibrosus cells treated with 0% fetal
bovine serum for forty-eight hours. However, when the cells
were treated with 0.5 μM staurosporine for twenty-four
hours, a markedly (3.1 times) increased number of the cells
with increased JC-1 fluorescence (diminished mitochondrial
membrane potential) was observed compared with that seen
in 10% fetal bovine serum for forty-eight hours (p < 0.001)
(Fig. 5-A). While cytochrome-c protein levels in the cytosolic
fractions of the cells treated with 0% fetal bovine serum for
forty-eight hours showed no substantial increase, the protein
level was markedly increased in the cells treated with 0.5 μM
staurosporine for twenty-four hours (Fig. 5-B).
Pancaspase Inhibitors and Caspase-8 Inhibitors Reduce 
Fas-Mediated Apoptosis of Rat Anulus Fibrosus Cells
In order to prove that caspase-8, 9, and 3 were actually involved
Fig. 4-C
The fold increase in caspase activity. ***p < 0.001. *p < 0.05.
777
 TH E JOUR NAL OF BONE & JOINT SURGER Y ·  JBJS .ORG
VO LU M E 88-A ·  NU M B E R 4 ·  APR IL 2006
AN T I-AP OP TO T IC EF F E C T S OF CA S P A S E INHIBITORS 
ON RA T INTER VER TEBR AL DISC CE L L S
in sensitization of rat anulus fibrosus cells to Fas-mediated
apoptosis, we next examined the effects of caspase-8 and 9 and
pancaspase inhibitors on Fas-mediated apoptosis. Flow cyto-
metric analysis revealed that Fas-mediated apoptosis of rat anu-
lus fibrosus cells (30% cell death) was significantly reduced by
Z-VAD-FMK (to 17%, p < 0.001) and Boc-D-FMK (to 10%,
p < 0.001), which are pancaspase inhibitors, and by Z-IETD-
FMK (to 22%, p < 0.05), which is a caspase-8 inhibitor. How-
ever, Z-LEHD-FMK (a caspase-9 inhibitor) did not reduce apo-
ptotic cell death, which was still 30% (p = 1) (Fig. 6). These
results indicate that rat anulus fibrosus cells undergo apoptosis
through the Fas Type-I pathway in serum deprivation.
Discussion
xcessive apoptosis of disc cells has been suggested as a po-
tential cause of disc degeneration3,15,16. We recently re-
ported that nucleus pulposus cells are Fas Type-II cells, which
undergo apoptosis through a mitochondrial pathway, and that
caspases are initiators or executioners of apoptosis of nucleus
pulposus cells18. There are also inhibitors of caspases, which
have the potential for being used as anti-apoptotic therapeutic
agents. Therefore, one possible therapeutic approach to mod-
ulating the process of disc degeneration may involve the inhi-
bition of apoptosis of disc cells by caspase inhibitors. To our
knowledge, therapeutic inhibition to prevent or attenuate
apoptosis of intervertebral disc cells has not been previously
investigated. Moreover, the apoptotic pathway for anulus fi-
brosus cells, which is phenotypically different from that for
nucleus pulposus cells, has not been clearly determined.
Therefore, in the current study, we tried to determine the anti-
apoptotic effects of caspase inhibitors as well as the apoptotic
pathway of anulus fibrosus cells.
In anulus fibrosus cells treated with serum deprivation
(0%), there was a significant increase in Fas expression fol-
lowed by sequential activation of caspase-8 (initiator) and
caspase-3 (executioner), resulting in apoptosis of anulus fibro-
sus cells. In contrast to the findings in disc cells treated with
staurosporine, the loss of mitochondrial membrane potential
and the release of cytochrome-c into cytosol were not found
in 0% serum. These findings suggest that, unlike nucleus pul-
posus cells, anulus fibrosus cells subjected to serum depriva-
tion are Fas Type-I cells, which produce large quantities of
caspase-8 and do not involve mitochondria.
We also tested the therapeutic effect of caspase inhibitors
on apoptosis of anulus fibrosus cells in a serum deprivation
model. We found that anulus fibrosus cells treated with pan-
caspase inhibitors and a caspase-8 inhibitor demonstrated a sig-
nificant reduction of apoptosis, whereas the cells treated with a
caspase-9 inhibitor did not exhibit any inhibition of apoptosis.
Pancaspase inhibition more effectively decreased apoptosis than
did caspase-8 inhibition. The use of caspase inhibitors has been
reported to prevent or attenuate cell death associated with is-
chemic injury in the brain and heart and to protect against
hepatic toxicity1,8-13. Our results suggest that pancaspase inhibi-
tors might offer a therapeutic benefit in the treatment of disc
degeneration.
The finding that caspase-9 activity, a marker of the Fas
Type-II (mitochondrial) pathway, increased simultaneously
with an increase in caspase-8 activity was an unexpected and
inexplicable result in the current study. However, we also found
that the specific caspase-9 inhibitor did not reduce the apop-
E
Fig. 5-A
Figs. 5-A and 5-B Assay for the mitochondrial pathway. Fig. 5-A No sub-
stantial change in the mitochondrial membrane potential (MMP) was 
found in anulus fibrosus cells treated with 0% fetal bovine serum (SD) 
for forty-eight hours. However, when the cells were treated with 0.5 μM 
staurosporine (STS) for twenty-four hours, a markedly increased num-
ber of cells with increased JC-1 fluorescence was observed. CTL = con-
trol (10% fetal bovine serum). ***p < 0.001.
Fig. 5-B
Western blot analysis showing the expression of cytochrome-c in anu-
lus fibrosus cells treated with 0.5 μM staurosporine (STS) for twenty-
four hours but not in the cells treated with 0% fetal bovine serum (SD) 
for forty-eight hours. CTL = control (10% fetal bovine serum). 
778
 TH E JOUR NAL OF BONE & JOINT SURGER Y ·  JBJS .ORG
VO LU M E 88-A ·  NU M B E R 4 ·  APR IL 2006
AN T I-AP OP TO T IC EF F E C T S OF CA S P A S E INHIBITORS 
ON RA T INTER VER TEBR AL DISC CE L L S
tosis of anulus fibrosus cells at all. These findings need to be
investigated further.
Rannou et al.24 previously reported that mechanical over-
load-induced apoptosis of anulus fibrosus cells is mediated
through the mitochondrial pathway. Their results are contra-
dictory to those of our study. However, it has been known
that apoptotic signal transduction pathways are cell-type and
stimulus-specific7,25. Therefore, multiple apoptotic pathways
can be activated in the same cell type in response to different
triggering stimuli. In view of the results reported by Rannou et
al. and those found in our study, we believe that the activation
of multiple apoptotic pathways of anulus fibrosus cells is pos-
sible, depending on triggering stimuli such as serum depriva-
tion or cyclic stretching.
In the current study, we used the percentage of cell death
as the primary outcome measure, but it is also important to as-
sess cellular function, such as the ability to produce collagens
and proteoglycans. It is assumed that apoptosis is undesirable
and prevention of cell death should enhance normal structure
and function. Programmed cell death or cell turnover might be
essential to disc metabolism and might not be detrimental.
In fact, cell survival alone without proper function such as
matrix synthesis might not be desirable. Even if cells do sur-
vive longer with caspase inhibitors, if nutrition is lost, cell
death is inevitable.
In conclusion, our results strongly demonstrate a cen-
tral role of caspases in the apoptosis of disc cells. The efficacy
of caspase inhibitors in attenuating or preventing apoptosis of
disc cells suggests that such inhibitors may potentially repre-
sent a novel treatment of disc degeneration due to inappropri-
ate or excessive apoptosis of intervertebral disc cells. 
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